Cardiovascular Risk Assessment and Dynamic Monitoring-based Prevention Trial
Recruiting
N/A
Interventional Study
Cardiovascular Diseases
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 40 – 79
- Sex
- Any
- Study type
- Interventional
- Purpose
- Prevention
- Participants needed
- 22,032 (estimated)
- Sponsor
- Peking University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The CRITICALLY study is a cluster randomized trial that will evaluate the effectiveness of a risk-based dynamic monitoring strategy for the primary prevention of cardiovascular high-risk Chinese adults.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Residents in the Yinzhou District have a unique health ID;
* Aged 40 to 79 years at the baseline enrollment;
* With high risk of cardiovascular disease evaluated by the 2019 WHO laboratory-based risk models (10-year risk≥10%);
Exclusion Criteria:
* Have a history of coronary…
Contacts